The company showed modest financial improvements with increased revenue and adjusted EBITDA, but faced challenges like tariff pressures, competitive pricing, and rising costs. The Q&A revealed strategic growth plans, but management's unclear response on tariffs raises concerns. Facility expansions and M&A strategies are positive, yet risks remain. Overall, mixed signals suggest a neutral stock price movement.